Daily13 小时
Primary Ciliary Dyskinesia in Childhood: Study Reveals High Burden of ENT Morbidity
USA: A recent study has shed light on the progression of otologic and nasal symptoms in children with primary ciliary ...
The Pharma Letter3 天
Phase IV Ingrezza data move focus from sales outlook
Neurocrine Biosciences (Nasdaq: NBIX) has announced positive results from its Phase IV KINECT-PRO study, showing that ...
Neurocrine reports patient-reported outcome data from KINECT-PRO study
Biosciences announced top-line data from a Phase 4 study, KINECT-PRO, demonstrating clinically meaningful and sustained ...
Taiwan News4 天
Supernus to Participate in the TD Cowen 45th Annual Health Care Conference
Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, announced ...
theasianparent.com4 天
Dextrocardia: Symptoms, Causes, Risk Factors and Possible Complications
Dextrocardia adalah kondisi langka yang bisa menyerang jantung bayi. Beberapa kasus tidak memerlukan penanganan khusus. Baca ...
IRLAB Therapeutics: IRLAB Publishes Phase IIb Data on Mesdopetam in Movement Disorders ...
GOTHENBURG, SWEDEN / ACCESS Newswire / February 27, 2025 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, February 27, 2025 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a compa ...
Le Lézard4 天
IRLAB Publishes Phase IIb Data on Mesdopetam in Movement Disorders Clinical Practice
GOTHENBURG, SWEDEN / ACCESS Newswire / February 27, 2025 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, February 27, 2025 - IRLAB Therapeutics AB , a company that discovers and ...
Neurocrine Biosciences to Present at Upcoming Investor Conferences in March
The live webcasts can be accessed on Neurocrine Biosciences' website under Investors at A replay of the webcasts will be available on the website approximately ...